Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN 1997-6933 (print)
ISSN 2500-2139 (online)
Русский English
  • Register
  • Login
Skip to main content Skip to main navigation menu Skip to site footer
Clinical Oncohematology
Basic Research and Clinical Practice

ИФ РИНЦ:     0,587
H-INDEX:        16

  • Home
  • About the Journal
    • Aims and Scope
    • Editorial Masthead
    • Peer Review
    • Publishing Ethics and Malpractice Statement
    • Indexing and Abstracting
    • Ownership, management and funding
    • Open Access Policy and Publication Fee
  • Articles
    • Current
    • Journal pre-proofs
    • Archive
    • SUPPLEMENT
  • Sections
    • LYMPHOID TUMORS
    • MYELOID TUMORS
    • BONE MARROW TRANSPLANTATION
    • ANEMIAS
    • AUTOIMMUNE DISEASES
    • CLINICAL TRIALS
    • NOVEL CORONAVIRUS INFECTION
    • NEWS
    • NEW TECHNOLOGIES
    • REVIEWS
    • COMPLICATIONS OF CHEMOTHERAPY
    • PRACTICAL RECOMMENDATIONS
    • RARE HEMATOLOGICAL TUMORS AND SYNDROMES
    • EXPERIMENTAL STUDIES
  • Submission
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • New Possibilities of Treatment for Relapsed/Refractory Multiple Myeloma: A Literature Review

    Ol’ga Mikhailovna Votyakova
    425-434
    01.10.2017
  • Certain Aspects of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma

    Sergei Vasil’evich Gritsaev, A.A. Kuzyaeva, S.S. Bessmel’tsev
    7-12
    01.01.2017
  • Diagnostic and Prognostic Value of Biochemical Markers of Infectious Complications of High-Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation in Malignant Lymphoproliferative Diseases

    Vladislav Olegovich Sarzhevskii, Yu.N. Dubinina, V.Ya. Mel’nichenko
    113-119
    01.01.2017
  • Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders

    Vladislav Olegovich Sarzhevskii, D.S. Kolesnikova, V.Ya. Mel’nichenko
    465-473
    01.10.2016
  • Role of Positron-Emission Tomography in Prognosis of Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Hodgkin’s Lymphoma

    Vsevolod Gennad’evich Potapenko, N.B. Mikhailova, B.I. Smirnov, I.A. Skorokhod, D.A. Chaginskaya, V.V. Ryabchikova, I.A. Samorodova, E.I. Podol’tseva, V.V. Ipatov, I.V. Boikov, V.N. Semelev, D.A. Gornostaev, T.G. Potapenko, T.G. Kulibaba, N.V. Medvedeva, B.V. Afanas’ev
    406-412
    01.10.2016
  • Brentuximab Vedotin: New Possibilities for Treatment of Relapses and Refractory Hodgkin’s Lymphomas

    Elena Andreevna Demina
    398-405
    01.10.2016
  • Plerixafor in Patients with Decreased Mobilizing Ability of Autologous Hematopoietic Stem Cells

    Maksim Anatol’evich Kucher, М.S. Motalkina, О.U. Klimova, Е.V. Kondakova, О.B. Kalashnikova, S.М. Alekseev, D.V. Motorin, D.V. Babenetskaya, E.I. Podol’tseva, N.B. Mikhailova, М.А. Estrina, Е.V. Babenko, A.Yu. Zaritskii, B.V. Afanas’ev
    155-161
    01.04.2016
  • Autologous Stem Cell Transplantation in Primary Refractory Hodgkin’s Lymphoma: Supposed Zugzwang or Zwischenzug?

    Galina Dmitrievna Petrova, K.N. Melkova, T.Z. Chernyavskaya, N.V. Gorbunova, B.V. Afanas’ev, E.A. Demina, V.N. Kostrykina, V.A. Doronin
    321-330
    01.07.2015
  • Single-Photon Emission Computed Tomography Synchronized with ECG as Method for Evaluation of Cardiotoxicity of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation for Malignant Lymphoproliferative Disorders

    Vladislav Olegovich Sarzhevskii, D.S. Kolesnikova, M.N. Vakhromeeva, V.Ya. Mel’nichenko
    84–90
    01.01.2015
  • Quality of Life of Patients with Lymphomas at Different Time-Points after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

    N.E. Mochkin, D.A. Fedorenko, V.Ya. Mel’nichenko, T.I. Ionova, T.P. Nikitina, K.A. Kurbatova, A.A. Novik
    577-582
    01.10.2014
  • High-Dose Chemotherapy and Autologous Stem Cells Transplantation for Relapsed/Refractory Hodgkin’s Lymphoma. Is There an Equal Right to Life?

    N.V. Zhukov, A.G. Rumyantsev, A.L. Uss, N.F. Milanovich, V.V. Ptushkin, B.V. Afanasyev, N.B. Mikhaylova, V.B. Larionova, E.A. Demina, E.E. Karamanesht, N.G. Tyurina, M.A. Vernyuk, A.D. Kaprin
    317-326
    01.07.2014
  • Pulmonary complications of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with hematological malignancies

    V.O. Sarzhevskiy, V.Ya. Melnichenko, V.P. Tyurin
    76-85
    01.01.2014
  • Current therapies for AL amyloidosis: literature review and our data

    A.G. Smirnova, S.N. Bondarenko, A.A. Kisina, A.V. Smirnov, A. Tsander, B.V. Afanasyev
    303-311
    01.07.2013
41 - 53 of 53 items << < 1 2 

oa-antiplagiat

Антиплагиат

Make a Submission

Make a Submission

Banner ROHS

Russian Oncohematology Society

Indexing Databases

  • ISSN
  • cyberleninka cyberleninka
  • DOAJ
  • Web of Science
  • Scopus
  • Elsevier
  • CAS Source Index (CASSI)
  • NLM Catalog
  • British Library
  • РИНЦ
  • Science Index
  • SCImago
  • The European Library
  • Scholia
  • Journal Observatory
  • Scholar Google
  • IPR Smart
  • RSL
  • Ulrich's Serials Analysis System
  • ВИНИТИ
  • WorldCat
  • Research4Life
  • Lens
  • Mendeley
  • MIAR
  • OpenCitations
  • xueshu
  • OpenAlex
  • Scilit
  • Wikidata
  • na.neicon
  • Internet Archive scholar
  • ZDB catalogue
  • Keepers ISSN
  • RusMed
  • RCSI

Editor-in-Chief

Gayane Sepugovna Tumyan

ARCHIVE

2026
  • Issue 1 (2026)
2025
  • Issue 1 (2025)
  • Issue 2 (2025)
  • Issue 3 (2025)
  • Issue 4 (2025)
2024
  • Issue 1 (2024)
  • Issue 2 (2024)
  • Issue 3 (2024)
  • Issue 4 (2024)
2023
  • Issue 1 (2023)
  • Issue 2 (2023)
  • Issue 3 (2023)
  • Issue 4 (2023)
2022
  • Issue 1 (2022)
  • Issue 2 (2022)
  • Issue 3 (2022)
  • Issue 4 (2022)
2021
  • Issue 1 (2021)
  • Issue 2 (2021)
  • Issue 3 (2021)
  • Issue 4 (2021)
2020
  • Issue 1 (2020)
  • Issue 2 (2020)
  • Issue 3 (2020)
  • Issue 4 (2020)
2019
  • Issue 1 (2019)
  • Issue 2 (2019)
  • Issue 3 (2019)
  • Issue 4 (2019)
2018
  • Issue 1 (2018)
  • Issue 2 (2018)
  • Issue 3 (2018)
  • Issue 4 (2018)
2017
  • Issue 1 (2017)
  • Issue 2 (2017)
  • Issue 3 (2017)
  • Issue 4 (2017)
2016
  • Issue 1 (2016)
  • Issue 2 (2016)
  • Issue 3 (2016)
  • Issue 4 (2016)
2015
  • Issue 1 (2015)
  • Issue 2 (2015)
  • Issue 3 (2015)
  • Issue 4 (2015)
2014
  • Issue 1 (2014)
  • Issue 2 (2014)
  • Issue 3 (2014)
  • Issue 4 (2014)
2013
  • Issue 1 (2013)
  • Issue 2 (2013)
  • Issue 3 (2013)
  • Issue 4 (2013)
ALL ARCHIVE

Keywords

Most Read Articles
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
    3416
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
    1338
  • Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis
    884
  • Anemia of Chronic Diseases
    854
  • Multiple myeloma (pathogenesis, clinical features, diagnosis, differential diagnosis). Part I
    852

Partners

Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI
Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI

«PRACTICAL MEDICINE» LLC
115201, Moscow, 1st Kotlyakovsky Pereulok 3
Phone. +7 (495) 324-93-29
E-mail: org@bloodjournal.ru
medprint.ru


Copyright © Clinical Oncohematology. Basic Research and Clinical Practice 2026

Up